These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8598371)

  • 21. Biologic treatment planning for high-dose-rate brachytherapy.
    Manning MA; Zwicker RD; Arthur DW; Arnfield M
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):839-45. PubMed ID: 11172968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose optimization of breast balloon brachytherapy using a stepping 192Ir HDR source.
    Choi CH; Ye SJ; Parsai EI; Shen S; Meredith R; Brezovich IA; Ove R
    J Appl Clin Med Phys; 2009 Feb; 10(1):90-102. PubMed ID: 19223839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.
    Dickler A; Kirk M; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):469-74. PubMed ID: 15145164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of interstitial volume implants.
    Kolkman-Deurloo IK; Visser AG; Niël CG; Driver N; Levendag PC
    Radiother Oncol; 1994 Jun; 31(3):229-39. PubMed ID: 8066206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dosimetry system for 192IR interstitial breast implants performed at the time of lumpectomy.
    Waterman FM; Mansfield CM; Komarnicky L; Anne PR; Corn B; Suntharalingam N
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):229-35. PubMed ID: 9054900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of interstitial implants.
    Saw CB; Suntharalingam N
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):135-9. PubMed ID: 1993622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
    Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.
    Zhang H; Donnelly ED; Strauss JB; Qi Y
    Med Phys; 2016 Jan; 43(1):483. PubMed ID: 26745941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
    Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uniformity of biological effect in high-dose rate stepping source brachytherapy: an in vitro study.
    Furuta M; Tsukiyama I; Kano Y
    Eur J Cancer; 1999 May; 35(5):782-6. PubMed ID: 10505040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of transit dose profile for a (192)Ir HDR source.
    Fonseca GP; Rubo RA; Minamisawa RA; dos Santos GR; Antunes PC; Yoriyaz H
    Med Phys; 2013 May; 40(5):051717. PubMed ID: 23635265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose error from deviation of dwell time and source position for high dose-rate 192Ir in remote afterloading system.
    Okamoto H; Aikawa A; Wakita A; Yoshio K; Murakami N; Nakamura S; Hamada M; Abe Y; Itami J
    J Radiat Res; 2014 Jul; 55(4):780-7. PubMed ID: 24566719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the substitution of Ir-192 seed ribbons for wires in Paris system using dose nonuniformity ratio.
    Saw CB; Wu A
    Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):551-6. PubMed ID: 8436534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Nickers P; Lenaerts E; Thissen B; Deneufbourg JM
    Radiother Oncol; 2005 Feb; 74(2):131-6. PubMed ID: 15734200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
    Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.